Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2026-02-25 @ 9:39 PM
Study NCT ID:
NCT02651259
Status:
COMPLETED
Last Update Posted:
2021-11-04
First Post:
2016-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum Women
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-07
First Submit QC Date:
None
Study First Post Date:
2016-01-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-04-03
Results First Submit QC Date:
None
Results First Post Date:
2020-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-02
Last Update Post Date:
2021-11-04
Last Update Post Date Type:
ACTUAL